ARTG 304101BioJet - Radionuclide system, therapeutic, brachytherapy, application program software
ARTG ID: 304101 · Ultramed · Medical Targeting Technologies GmbH · Class IIb · Started June 08, 2018
Good Name: Ultramed - BioJet - Radionuclide system, therapeutic, brachytherapy, application program software
- Risk Class
- Class IIb
- Product Type
- Medical device system
- ARTG Category
- General
- ARTG ID
- 304101
- Start Date
- June 08, 2018
- Effective Date
- June 08, 2018
- Name
- Ultramed
- Country
- Germany
- Address
- Kanalweg 7/8, Barum, 21357
The BioJet Software System is intended to be used by physicians in the clinic or hospital for 2D and 3D visualization of ultrasound images of the prostate gland. Additional software features include patient data management, multi-planar reconstruction, segmentation, image measurements, 3D registration. This device provides the capability to overlay annotations on 2D medical image displays. These annotations may represent the position of instruments including but not limited to biopsy needles, guidance wires, imaging probes or other tracked devices.
Access comprehensive regulatory information for BioJet - Radionuclide system, therapeutic, brachytherapy, application program software in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 304101 and sponsored by Ultramed, manufactured by Medical Targeting Technologies GmbH in Germany. The device registration started on June 08, 2018.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.